Despite the COVID-19 impact, the global Hepatitis B Diagnostic Tests Market grew at a solid year-on-year (YoY) rate, reaching a valuation of roughly US$ 872.5 Million in 2022. With the rising incidence of hepatitis B globally, the total market is expected to grow at a CAGR of 6.4% between 2022 and 2028, achieving a.
Hepatitis B Diagnostic Tests Market is forecast to register a CAGR of 6 4% through 2028 | FMI fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
The ELISA market is expected to prosper due to factors such as the increasing prevalence of infectious diseases such as HIV, tuberculosis, malaria, and hepatitis B, among others, growing application
/PRNewswire/ The "Lateral Flow Assays Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com s offering. The global.